Ayaki Tanaka
Tanaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic criteria and clinical outcomes of chronic nasopharyngitis treated with nasopharyngeal abrasive therapy: A multicenter prospective study.
Journal: Auris, nasus, larynx
Published: February 08, 2026
Retraction: Chronic Epipharyngitis Treated with Epipharyngeal Abrasion Therapy: Symptoms, Diagnosis, Pathogenesis, and Treatment Outcomes.
Journal: JMA journal
Published: May 26, 2025
Retracted: Chronic Epipharyngitis Treated with Epipharyngeal Abrasion Therapy: Symptoms, Diagnosis, Pathogenesis, and Treatment Outcomes.
Journal: JMA journal
Published: January 13, 2025
Epipharyngeal Abrasive Therapy (EAT) Reduces the mRNA Expression of Major Proinflammatory Cytokine IL-6 in Chronic Epipharyngitis.
Journal: International journal of molecular sciences
Published: August 01, 2022
Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment.
Journal: Viruses
Published: April 16, 2022
Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy.
Journal: International journal of molecular sciences
Published: December 23, 2021
Chronic epipharyngitis: A missing background of IgA nephropathy.
Journal: Autoimmunity reviews
Published: April 06, 2019
Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).
Journal: Immunologic research
Published: September 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026